ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

Brown’s appointment may Be Delayed Until After Jan. 20

January 14, 1977

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

Clinical Trials Approved By NCI During November Are Listed

December 27, 2002

Treat Cancer, But Protect Heart Anderson Cardiologists Warn

July 30, 2004